Literature DB >> 23107952

Coaxial electrospinning with acetic acid for preparing ferulic acid/zein composite fibers with improved drug release profiles.

Jian-Mao Yang1, Liu-sheng Zha, Deng-Guang Yu, Jianyun Liu.   

Abstract

This study investigated drug/zein composite fibers prepared using a modified coaxial electrospinning process. With unspinnable acetic acid as sheath liquid and an electrospinnable co-dissolving solution of zein and ferulic acid (FA) as core fluid, the modified coaxial process could run smoothly and continuously without any clogging. Compared with those from the single-fluid electrospinning process, the FA-loaded zein fibers from the modified process were rounder and possessed higher quality in terms of diameter and distribution, as verified by scanning electron microscopic observations of their surface and cross-section. Differential scanning calorimetry and X-ray diffraction showed that fibers from both processes similarly formed a composite with the FA present in the zein matrix in an amorphous state. The driving force of encapsulation of FA into zein fibers was hydrogen bonding, as evidenced by the attenuated total reflectance Fourier transform infrared spectra. However, in vitro dissolution tests demonstrated that the fibers from the coaxial process exhibited better sustained-release profiles with a smaller initial burst effect and less tailing-off release compared with those from the single process. The modified coaxial electrospinning process is a useful tool for generating nanofibers with higher quality and improved functional performance.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23107952     DOI: 10.1016/j.colsurfb.2012.09.039

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  13 in total

1.  Zein/polycaprolactone electrospun matrices for localised controlled delivery of tetracycline.

Authors:  Nour Alhusein; Ian S Blagbrough; Paul A De Bank
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 2.  In pursuit of functional electrospun materials for clinical applications in humans.

Authors:  Ryan J Stoddard; Arielle L Steger; Anna K Blakney; Kim A Woodrow
Journal:  Ther Deliv       Date:  2016-06-02

Review 3.  Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems.

Authors:  Hedieh Malekzad; Hamed Mirshekari; Parham Sahandi Zangabad; S M Moosavi Basri; Fazel Baniasadi; Maryam Sharifi Aghdam; Mahdi Karimi; Michael R Hamblin
Journal:  Crit Rev Biotechnol       Date:  2017-04-24       Impact factor: 8.429

Review 4.  Current strategies for sustaining drug release from electrospun nanofibers.

Authors:  Shih-Feng Chou; Daniel Carson; Kim A Woodrow
Journal:  J Control Release       Date:  2015-09-09       Impact factor: 9.776

Review 5.  Electrospun Nanofibers for Cancer Therapy.

Authors:  Huanhuan Luo; Tianyang Jie; Li Zheng; Chenglong Huang; Gang Chen; Wenguo Cui
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Antiproliferative activity of ferulic acid-encapsulated electrospun PLGA/PEO nanofibers against MCF-7 human breast carcinoma cells.

Authors:  Priya Vashisth; Mohit Sharma; Kumar Nikhil; Harmeet Singh; Richa Panwar; Parul A Pruthi; Vikas Pruthi
Journal:  3 Biotech       Date:  2014-06-19       Impact factor: 2.406

7.  Biomedical applications of ferulic acid encapsulated electrospun nanofibers.

Authors:  Priya Vashisth; Naresh Kumar; Mohit Sharma; Vikas Pruthi
Journal:  Biotechnol Rep (Amst)       Date:  2015-09-14

8.  Active Food Packaging Coatings Based on Hybrid Electrospun Gliadin Nanofibers Containing Ferulic Acid/Hydroxypropyl-Beta-Cyclodextrin Inclusion Complexes.

Authors:  Niloufar Sharif; Mohammad-Taghi Golmakani; Mehrdad Niakousari; Seyed Mohammad Hashem Hosseini; Behrouz Ghorani; Amparo Lopez-Rubio
Journal:  Nanomaterials (Basel)       Date:  2018-11-07       Impact factor: 5.076

Review 9.  Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications.

Authors:  Kevin M Tyo; Farnaz Minooei; Keegan C Curry; Sarah M NeCamp; Danielle L Graves; Joel R Fried; Jill M Steinbach-Rankins
Journal:  Pharmaceutics       Date:  2019-04-03       Impact factor: 6.321

10.  Ferulic acid-loaded collagen hydrolysate and polycaprolactone nanofibres for tissue engineering applications.

Authors:  Chinnaiyan Senthil Kumar; Agnes Mary Soloman; Ramar Thangam; Ramesh Kannan Perumal; Arun Gopinath; Balaraman Madhan
Journal:  IET Nanobiotechnol       Date:  2020-05       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.